Sri Phoenixe Drugs & Chemicals Private Limited - Company Profile

It is a chemicals private limited company based in Bachupally, Telangana, India, established in 2020.

2020 Bachupally, Telangana, India Active

Last Updated: February 25, 2026

About Sri Phoenixe Drugs & Chemicals Private Limited

Sri Phoenixe Drugs & Chemicals Private Limited, a active private limited company, was established on 19 February 2020 in Bachupally, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239TG2020PTC139354. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Gangadhara Rao Paladugu (Director), Yarlagadda Vinoothna Chowdhary (Director). It is based at P No 34 & 37, Flat No 405, 4Th Floor Vijaya Chambers, Balaji Nagar, Nizampet, Bachupally, Telangana, 500090.

Company Details

CIN/LLPIN
U24239TG2020PTC139354
Registration Number
139354
Incorporation Date
19 February 2020
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.10 M as on 25-02-2026
Paid Up Capital ₹ 0.10 M as on 25-02-2026
Company Age 6 Year, 10 Days

Comprehensive Company Insights

Explore comprehensive insights into Sri Phoenixe Drugs & Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sri Phoenixe Drugs & Chemicals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Gangadhara Rao Paladugu	Director	19 Feb 2020	Current
Yarlagadda Vinoothna Chowdhary	Director	19 Feb 2020	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Phoenixe Drugs & Chemicals.

Enhance accessibility to Sri Phoenixe Drugs & Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Phoenixe Drugs & Chemicals?

Unlock access to Sri Phoenixe Drugs & Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sri Phoenixe Drugs & Chemicals?

Unlock and access historical data on people associated with Sri Phoenixe Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sri Phoenixe Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Phoenixe Drugs & Chemicals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Phoenixe Drugs & Chemicals

Recent Activity within the Organization

Director Appointment

Progress on Gangadhara Rao Paladugu was appointed as a Director was appointed as a Director on 19 Feb 2020 & has been associated with this company since 6 years 10 days . was documented.
19 Feb 2020
Director Appointment

The activity Yarlagadda Vinoothna Chowdhary was appointed as a Director was appointed as a Director on 19 Feb 2020 & has been associated with this company since 6 years 10 days . was completed.
19 Feb 2020
Company Incorporation

The activity Sri Phoenixe Drugs & Chemicals Private Limited was registered on 19 Feb 2020 with Roc Hyderabad & aged 6 years 10 days as per MCA records. was completed.
19 Feb 2020

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Sri Phoenixe Drugs & Chemicals Private Limited?

The CIN of Sri Phoenixe Drugs & Chemicals Private Limited is U24239TG2020PTC139354.

Where is Sri Phoenixe Drugs & Chemicals Private Limited headquartered?

Sri Phoenixe Drugs & Chemicals Private Limited is headquartered at P No 34 & 37, Flat No 405, 4Th Floor Vijaya Chambers, Balaji Nagar, Nizampet, Bachupally, Telangana, 500090.

When was Sri Phoenixe Drugs & Chemicals Private Limited incorporated?

Sri Phoenixe Drugs & Chemicals Private Limited was incorporated on 19 February 2020.

Who are the current directors of Sri Phoenixe Drugs & Chemicals Private Limited?

The current directors of Sri Phoenixe Drugs & Chemicals Private Limited are

What is the primary industry of Sri Phoenixe Drugs & Chemicals Private Limited?

The primary industry of Sri Phoenixe Drugs & Chemicals Private Limited is Chemicals.

Is Sri Phoenixe Drugs & Chemicals Private Limited a listed company?

Sri Phoenixe Drugs & Chemicals Private Limited is unlisted.

What is the capital structure of Sri Phoenixe Drugs & Chemicals Private Limited?

The authorized capital of Sri Phoenixe Drugs & Chemicals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available